Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
total_cholesterol [2025/01/28 04:44] – admin | total_cholesterol [2025/01/28 05:01] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | | + | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| |
+ | |||
+ | Total Cholesterol Examination Procedure | ||
**1.Purpose of Examination: | **1.Purpose of Examination: | ||
To lay down standard operating procedure for serum Total Cholesterol estimation by CHOD-PAP Method in Biochemistry section of LSSTH, Bhavnagar. | To lay down standard operating procedure for serum Total Cholesterol estimation by CHOD-PAP Method in Biochemistry section of LSSTH, Bhavnagar. | ||
- | **2.Principle of the procedure used for examinations: | ||
- | 1)Cholesterol ester+H2O | ||
- | | ||
- | Cholesterol+F.A | ||
- | | + | **2.Principle of the procedure used for examinations: |
- | | + | The Cholesterol2 assay is an automated clinical chemistry assay. Cholesterol esters are enzymatically hydrolyzed by cholesterol esterase to cholesterol and free fatty acids. Free cholesterol, |
- | | + | (quinoneimine |
- | Which is quantitated at 500 nm. | + | |
**3.Performance: | **3.Performance: | ||
Line 19: | Line 16: | ||
**4.Type of Primary Sample:** | **4.Type of Primary Sample:** | ||
- | Serum or Plasma | + | Serum or Plasma |
**5.Patient Preparation: | **5.Patient Preparation: | ||
Line 33: | Line 30: | ||
**8.Enviromental & Safety control:** | **8.Enviromental & Safety control:** | ||
- | Reagent R1 contains sodium azide.contact with acids liberates very toxic gas | + | Reagent R1 contains sodium azide. contact with acids liberates very toxic gas |
**9.Precautions: | **9.Precautions: | ||
Line 86: | Line 83: | ||
* Automated Dilution Protocol | * Automated Dilution Protocol | ||
* When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. | * When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. | ||
+ | |||
**17.Manual Dilution Procedure: | **17.Manual Dilution Procedure: | ||
* Dilute the specimen with saline (0.85% to 0.90% NaCl). | * Dilute the specimen with saline (0.85% to 0.90% NaCl). | ||
* Enter the dilution factor in the Patient or Control order screen | * Enter the dilution factor in the Patient or Control order screen | ||
+ | |||
**18.Stability of sample** | **18.Stability of sample** | ||
Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours | Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours | ||
+ | |||
**19.Storage of sample** | **19.Storage of sample** | ||
- | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) | + | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) |
+ | |||
**20.Reagent Storage and stability** | **20.Reagent Storage and stability** | ||
Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | ||
+ | |||
**21.Turn around time (TAT)** | **21.Turn around time (TAT)** | ||
- | | + | 6.0 hours after collection, |
**22.Critical Value:**NA | **22.Critical Value:**NA | ||
Line 123: | Line 126: | ||
- NABL 112 effective from 01/06/2019 | - NABL 112 effective from 01/06/2019 | ||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Total Cholesterol Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||